To restart com­mon can­cer drug pro­duc­tion short­ly, FDA work­ing close­ly with Ac­cord

The short­age of the com­mon and cheap can­cer drugs cis­platin and car­bo­platin has been an on­go­ing, na­tion­al headache. But the FDA be­lieves that the sit­u­a­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER